MedTrace Logo

The CONFUCIUS Oral Protein Supplementation Trial

NCT05405764 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-09-25

No results posted yet for this study

Summary

Study the effect of 6-weeks porcine protein supplementation vs isocaloric comparator (carbohydrate) on functional outcomes in post ICU-patients. Patients will be included at ICU discharge. Included patients will receive the supplements twice daily (morning and afternoon), starting at the first day at the general ward.

To the best of our knowledge, a study on protein supplementation in the post-ICU period to address its effect on functional outcomes is lacking.

Conditions

  • Intensive Care Unit Acquired Weakness
  • Critical Illness

Interventions

DIETARY_SUPPLEMENT

Porcine protein supplement

Porcine protein supplementation

DIETARY_SUPPLEMENT

Control product maltodextrin supplement

Maltodextrin supplementation

Sponsors & Collaborators

  • Intensive Care Research Foundation, Gelderse Vallei Hospital

    collaborator UNKNOWN

  • Rousselot BVBA

    collaborator INDUSTRY

  • ARH van Zanten

    lead OTHER

Principal Investigators

  • Arthur RH van Zanten, MD, PhD · Gelderse Vallei Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-19
Primary Completion
2024-09-24
Completion
2024-09-24

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05405764 on ClinicalTrials.gov